Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 4Head and Neck Neoplasms 3Wilms Tumor 2Squamous Cell Carcinoma of Head and Neck 2Neurotoxicity Syndromes 2Lung Neoplasms 2Brain Neoplasms 2Untreated Childhood Medulloblastoma 1Tongue Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Intraductal Neoplasms 1Ototoxicity 1Oligodendroglioma 1Obesity 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leukemia, Myelomonocytic, Chronic 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Gliosarcoma 1

Interventions

dehydroftorafur 1X-Rays 1Specimen Handling 1Secretin 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pancreatic Intraductal Neoplasms × Radiotherapy, Conformal × Clear all
NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡